Skip to content

A Retrospective Study to Understand the Clinical Management of Subjects With Multiple Sclerosis at a Site in Taiwan Over the Last 10 Years

A Retrospective Study On The Management of Multiple Sclerosis (MS) Over The Last 10 Years

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01084798
Enrollment
123
Registered
2010-03-11
Start date
2008-08-31
Completion date
2009-11-30
Last updated
2014-07-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Multiple Sclerosis

Keywords

Multiple sclerosis, Expanded Disability Status Scale, Sclerosis

Brief summary

This is an observational, non comparative, non-randomised, open-label, retrospective, single centre study planned to collect the data of subjects diagnosed with multiple sclerosis (MS) as per Poser or McDonald criteria between 1997 and 2007 in Taiwan. The clinical features and annual relapse rate in the first five years after the onset of disease have been compared between conventional and optico-spinal MS in the earlier studies. This study aims to understand the clinical care pathway of MS subjects and facilitate the subject's diagnosis before converting to MS.

Detailed description

Multiple Sclerosis is a chronic, inflammatory disease of the central nervous system (CNS) and is characterised by areas of demyelination, or plaques in the CNS. The disease is twice as prevalent in women as compared to men and causes considerable disability over time and continues for the lifetime of the subject. Subjects with MS are thought to have a genetic predisposition for the disease, though environmental factors such as geographic location and possibly viral infection also play an important role in the process of development of the disease. OBJECTIVES Primary objective: * To understand the clinical care pathways of MS subjects at the site over the last 10 years in order to raise the medical attention of MS diagnosis Secondary objective: * To review the pattern of MS treatment regimens in MS subjects at a particular site between 1997 and 2007

Interventions

None listed

Sponsors

Merck KGaA, Darmstadt, Germany
Lead SponsorINDUSTRY

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* Subjects diagnosed with MS as per Poser or McDonald criteria between 1997 and 2007 * EDSS before treatment was available if subject has started the disease modifying drug treatment.

Design outcomes

Primary

MeasureTime frame
Distribution of locations (medical centre, regional hospital, general practitioners) where subjects were treated for the first episode of attack prior to multiple sclerosis diagnosisData collected for last 10 years between 1997 and 2007

Secondary

MeasureTime frame
Distribution of MS diagnosis criteria and treatment regimensData collected for last 10 years between 1997 and 2007
Annual relapse rate before and after MS treatmentData collected for last 10 years between 1997 and 2007
Duration from first attack to confirmation of MSData collected for last 10 years between 1997 and 2007
Changes in VEP before and after treatmentData collected for last 10 years between 1997 and 2007
Association between baseline demographics/disease characteristics and MSData collected for last 10 years between 1997 and 2007
Changes in Expanded Disability Status Scale (EDSS) before and after treatmentData collected for last 10 years between 1997 and 2007

Countries

Taiwan

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026